XIFIN Named Top-Tier Software Vendor by APPS RUN THE WORLD in the APPS TOP 500 Market Report

XIFIN Strengths, Domain Expertise, and Key Differentiators

XiFin's competitive advantage stems from its extensive product portfolio and deep domain expertise. Its cloud-based workflow application and health economics optimization platform facilitate seamless connectivity across the healthcare ecosystem, improving both business efficiency and patient outcomes. Furthermore, strategic acquisitions, including PathCentral, have expanded XiFin's capabilities in pathology and molecular diagnostics, reinforcing its market leadership.

XIFIN Recent Developments

In January 2024, OmniSYS, XiFin's pharmacy division, reported a 28% increase in companion pneumococcal immunizations among participating pharmacies through its successful CareALERTS™ program. This initiative not only improves patient care but also generates a valuable revenue stream for pharmacies, contributing to reduced national healthcare costs.

In December 2023, XiFin introduced the Payor Rate Transparency Monitor, offering diagnostic providers and laboratories critical insights into managed care reimbursement rates. These initiatives underscore XiFin's ongoing commitment to leveraging technology to drive improved healthcare outcomes.

In August 2023, XiFin introduced an enhanced Lab Volume Index (LVI), providing deeper insights into post-pandemic diagnostic testing trends. Based on claims transaction data within the XiFin RPM platform, the updated LVI reveals a decline in COVID-19 testing while highlighting steady growth in overall molecular testing, particularly in women's health, including prenatal testing. The enhanced LVI offers expanded functionality, enabling users to compare testing volumes over time and gain valuable insights into the evolving diagnostic testing landscape.

XiFin has demonstrated impressive financial performance, achieving a 37% compound annual growth rate (CAGR) from 2019 to 2022. Strategic acquisitions, such as Computerized Management Services and OmniSYS, have played a key role in this growth, further cementing XiFin’s position as a leader in healthcare IT.

XIFIN Mergers and Acquisitions (M&A) Activities

In December 2021, XiFin announced the strategic acquisition of OmniSYS, a leading provider in the retail pharmacy sector. This acquisition broadens XiFin’s portfolio to support retail pharmacies transitioning to a clinical services model, fostering stronger collaboration between pharmacies and diagnostic providers. Aligned with the industry's shift toward pharmacies as primary and preventive care providers—accelerated by the COVID-19 pandemic and the growing consumerization of healthcare—this move enhances connectivity among consumers, pharmacies, payors, and laboratories. Through this integration, XiFin aims to advance personalized medicine and optimize care coordination.

In July 2021, XiFin acquired Computerized Management Services (CMS), a leading provider of outsourced financial services for the radiology market. Renowned for its comprehensive solutions, CMS specializes in optimizing client revenue and cash flow through advanced technology, seamless integrations, and data-driven analytics. Its service offerings include revenue cycle management (RCM), strategic consulting, credentialing, and coding, further enhancing XiFin’s capabilities in the radiology sector.

XIFIN Customers in ARTW Customer Database

Leveraging a rigorous data-centric research methodology, APPS RUN THE WORLD asks the simple question: Who’s buying XIFIN applications and why? And we provide the answers – supported by decades of research – to our clients around the world. Our Customer database has over 100 data fields that detail company usage of XIFIN and other enterprise apps by function, customer size, industry, location, implementation status, partner involvement, Line of Business Key Stakeholders and IT decision makers contact details. List of Verified XiFin RPM, XiFin BI, XiFin LIS, CareCLAIM, CareALERTS, OmniSYS, Strand-Rx, VisualStrata customers.

XIFIN Key Enterprise and Cloud Applications

XiFin RPM, XiFin BI, XiFin LIS, CareCLAIM, CareALERTS, OmniSYS, Strand-Rx, VisualStrata

XIFIN Revenues, $M:

XIFIN Revenue Breakdown By Type, $M:

XIFIN Enterprise Applications Revenues By Functional Markets, $M:

XIFIN Enterprise Applications Revenues By Verticals, $M:

XIFIN Revenues By Region, $M

XIFIN Direct vs Indirect sales

XIFIN Customers - Breakdown by Geo, Size, Vertical and Product

List of Verified XIFIN Customers

No. of XIFIN Customers: x

No. of XIFIN Enterprise Applications Customers: x

No. of XIFIN Cloud Customers: x

No. of XIFIN Cloud Subscribers: x

In 2024, XiFin expanded its customer portfolio with the addition of Carent Laboratory Solutions and Perry Health, both adopting the XiFin RPM solution.

XiFin serves a diverse customer base, including some of the largest public laboratories, integrated delivery networks, and retail pharmacies in the United States. Its solutions are trusted by leading organizations such as Northwell Health Labs, MercyOne, Perry Health, Sonora Quest Laboratories, Interpace Biosciences, and others.

XIFIN Market Opportunities, M&A and Geo Expansions

XiFin is poised to capitalize on significant market opportunities across both horizontal and vertical sectors. The company has strong potential to expand its footprint into new regions and industries while leveraging the increasing demand for cloud-based healthcare solutions. With a strategic focus on radiology, pharmacy, and hospital services, XiFin is well-positioned to drive the transformation of healthcare delivery through its advanced technology solutions.

XiFin’s recent appointments of Erik Sallee as CFO, John Kelly as CIO, and Harley Ross as Chief Commercial Officer highlight the company’s commitment to growth and innovation. With a strong emphasis on market expansion and technological advancement, XiFin is strategically positioned to shape the future of healthcare IT.

XIFIN Risks and Challenges

XiFin’s operations are currently limited to the United States, and this geographic restriction poses a challenge to the company’s growth and expansion opportunities.

XiFin faces risks associated with post-acquisition integration challenges and increasing market competition. Successfully scaling its customer base and mitigating these risks will be critical to ensuring sustained long-term growth and success.

XIFIN Ecosystem, Partners, Resellers and SI

In February 2025, CareVisio, a provider of healthcare technology solutions and prior authorization services, partnered with XiFin to improve operational efficiencies for diagnostic laboratories. This collaboration integrates CareVisio’s innovative PA services with XiFin’s industry-leading RCM solutions.

XiFin fosters and maintains strategic partnerships with clearinghouses, payors, government agencies, and other data sources, relieving its clients from the complexities of managing these relationships. The company works with two types of partners: those integrated with one or more of XiFin’s solutions, and those that are not. Key partners include Braintree, Carevisio, Concord Technologies, Consensus Cloud Solutions, Dolbey Systems, Ellkay, Fabric Genomics, Fiserv, FrontRunnerHC, GeBBS, Glidian, Matrix, Proscia, RevSpring, ScriptPro, Experian, and others.

Research Methodology

Data used in research reports are derived from publicly available documents, continuous surveys of applications vendors, customers, resellers, Independent Software Vendors, systems integrators and other verifiable sources.

Vendor shares and market forecast results are based on a combination of existing databases as well as demand side and supply side research conducted throughout the year with validation from vendors, customers, channel partners and documentations such as earnings releases and 10Q and 10K filings, vertical industry studies, regional and country-level statistics from public and private institutions(i.e. colleges, universities, government agencies and trade associations).

For additional information on our methodologies, here's the link: